Cargando…
Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain
Mutations in leucine-rich repeat kinase 2 (LRRK2) are recognized as the most frequent cause of Parkinson’s disease (PD). As a multidomain ROCO protein, LRRK2 is characterized by the presence of both a Ras-of-complex (ROC) GTPase domain and a kinase domain connected through the C-terminal of an ROC d...
Autores principales: | Li, Xinyi, Qi, Zengxin, Ni, Duan, Lu, Shaoyong, Chen, Liang, Chen, Xiangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467336/ https://www.ncbi.nlm.nih.gov/pubmed/34577121 http://dx.doi.org/10.3390/molecules26185647 |
Ejemplares similares
-
Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutations
por: Rudi, Katharina, et al.
Publicado: (2015) -
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism
por: Chen, Meng-Ling, et al.
Publicado: (2022) -
Doubly Constrained
C-terminal of Roc (COR)
Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2)
Dimerization
por: Pathak, Pragya, et al.
Publicado: (2023) -
Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways
por: Sancho, Rosa M., et al.
Publicado: (2009) -
PrimerROC: accurate condition-independent dimer prediction using ROC analysis
por: Johnston, Andrew D., et al.
Publicado: (2019)